Corrigendum: Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19

Ítems similars

• Corrigendum: Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19
  per: Tetiana Yatsenko, et al.
  Publicat: (2024-03-01)
• AP1 Transcription Factor in the Regulation of the Urokinase Plasminogen Activation System
  per: Petra Korać, et al.
  Publicat: (2026-05-01)
• Fibrinolysis regulation by platelets retaining plasminogen and tissue-type plasminogen activator on their surface
  per: T. Grinenko, et al.
  Publicat: (2019-12-01)
• Effect of Plasma Soluble Urokinase-Type Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 Levels in the Plasma of Babylon Women with Breast Cancer
  per: Sheerin H. Abbas, et al.
  Publicat: (2025-01-01)
• Serum levels of urokinase-type plasminogen activator in healthy dogs and oncologic canine patients
  per: Sofia C. Ramos, et al.
  Publicat: (2017-08-01)